Nestlé and Danone Under Fresh Scrutiny as Infant Formula Recall Scandal Deepens

May 20, 2026

PARIS — European authorities have launched criminal investigations into Nestlé and Danone, two of the world’s largest infant formula manufacturers, following revelations that the companies allegedly delayed alerting regulators about contamination with cereulide—a potentially harmful toxin produced by Bacillus cereus bacteria. The scandal, which has triggered wide-scale product recalls across nearly 70 countries and affected distribution channels in up to 99 nations, has raised serious questions about food safety protocols and corporate transparency within the infant nutrition industry.

Key Findings: What the Investigation Revealed

An investigative report published on Tuesday by a coalition of European public broadcasters—including Radio France, RTBF (Belgium), and RTS (Switzerland)—uncovered evidence that Nestlé detected low cereulide levels during internal quality checks in late November 2025. However, the media outlets allege that the company delayed issuing public warnings. While Nestlé held back 838,000 cans of infant formula at its northern France factory and other production sites around late December, products already on market shelves remained in distribution channels or in consumers’ homes for weeks without an immediate official recall.

Nestlé countered the allegations, stating it acted with full transparency and cooperated with authorities from “day one.” According to Nestlé’s timeline, it halted using all batches containing the contaminated ingredient after final verification on December 24, 2025, analyzed samples until January 3 to determine the exact scope of the issue, and initiated public recalls on January 5, 2026. The investigation also alleged that Nestlé carried out “silent” or unannounced product withdrawals in Austria and Germany as early as December 24, an allegation the Swiss corporate giant strongly contests.

The global contamination has been traced back to a specific batch of arachidonic acid (ARA) oil—a crucial fatty acid added to infant formula to support brain and eye development—sourced from a third-party supplier, CABIO Biotech, based in China.

Following Nestlé’s initial recall of its SMA and Little Steps brands, Danone subsequently recalled specific batches of its popular Aptamil and Cow & Gate formulas in January and February 2026. Private dairy giant Lactalis has also been drawn into the widening crisis, bringing the total number of major international corporations under intense legal and regulatory scrutiny to three.

Understanding Cereulide: The Toxin at the Center of the Scandal

Cereulide is an emetic (vomiting-inducing) toxin produced by specific spore-forming strains of Bacillus cereus bacteria. Unlike standard bacterial contaminants, cereulide presents a unique danger because it is highly heat-stable.

Critical Safety Note: Standard formula preparation practices—such as mixing powder with boiling water—will not deactivate or destroy the cereulide toxin if it is already present in the powder.

According to a joint rapid outbreak assessment by the European Food Safety Authority (EFSA) and the European Centre for Disease Prevention and Control (ECDC), 144 suspected and confirmed cases of cereulide intoxication were reported across 10 countries between January 1 and February 25, 2026.

While the majority of reported cases have been mild and self-limiting, multiple infants required hospitalization. Belgium remains the only nation to successfully report laboratory-confirmed human cases, identifying the toxin directly within clinical fecal samples from five affected infants. In the United Kingdom, the UK Health Security Agency (UKHSA) documented 36 clinical notifications of infants exhibiting symptoms consistent with the toxin after consuming the implicated formula batches.

Expert Commentary: What Medical Professionals Say

Medical experts emphasize that the biological vulnerability of newborns turns what would be a minor bout of food poisoning in adults into a potential medical emergency for an infant.

“Infants under six months of age have very immature immune systems and exceptionally limited fluid reserves,” explains Dr. Sarah Mitchell, a pediatric gastroenterologist at Great Ormond Street Hospital in London, who was not involved in the outbreak investigations. “Acute, persistent vomiting can deplete an infant’s hydration status with terrifying speed. While most of these cases resolve within a day, parents must monitor their babies closely. If an infant exhibits sudden lethargy, a flat refusal to feed, or shows signs of dry mouth and fewer wet diapers after feeding, they require immediate medical attention.”

In response to the crisis, EFSA scientists moved rapidly to establish strict temporary thresholds. The agency instituted an acute reference dose (ARfD) of 0.014 micrograms per kilogram ($\mu\text{g/kg}$) of body weight for cereulide in infants. Regulators determined that concentrations exceeding $0.054\,\mu\text{g/L}$ in infant formula and $0.1\,\mu\text{g/L}$ in follow-on formula could breach safe limits, providing authorities with clear actionable parameters that did not exist before this event.

Timeline of the Crisis

The regulatory and corporate timeline highlights the weeks surrounding the initial discovery and the subsequent wave of public alerts:

Counterarguments and Diagnostic Limitations

In maintaining an objective perspective, health authorities have urged the public to avoid panic. French health ministry officials and Nestlé legal representatives have emphasized that there is currently no scientific or medical evidence linking the recalled formula to the tragic deaths of two infants in France that originally prompted heightened judicial scrutiny. Medico-legal investigations remain active to definitively determine if any causal relationship exists.

Furthermore, the ECDC has noted significant diagnostic hurdles that complicate the true case count. Because cereulide poisoning symptoms mirror those of common viral gastroenteritis—which peaked widely across Europe during the winter months—many mild cases may have been misdiagnosed as routine stomach bugs. Conversely, some reported infant illnesses may have been entirely unrelated to the formula.

Financial Impact and Regulatory Future

The financial fallout for the infant milk formula (IMF) sector is mounting. Danone executives recently estimated that the targeted recalls would result in a €35 million to €70 million financial hit in the first quarter of 2026 alone, accounting for roughly 0.5% to 1% of net quarterly sales. Despite the setback, Danone Deputy CEO Juergen Esser defended the company’s timeline, stating they acted responsibly “as soon as the authorities changed the requirements.”

Meanwhile, tension is brewing between the corporate rivals. Nestlé leadership publically noted they “lost no time” in initiating voluntary recalls, expressing surprise that competitors took longer to act.

For the wider public health landscape, the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) has issued an urgent call for stricter supply-chain transparency and mandatory testing protocols regarding raw oil ingredients sourced globally. While the World Health Organization (WHO) currently assesses the ongoing public health risk as low-to-moderate now that the affected batches have been largely removed from circulation, the incident serves as a stark reminder of the vulnerabilities inherent in globalized food production.

Practical Guidance for Parents and Caregivers

If you currently have infant formula canisters at home, public health agencies recommend taking the following immediate steps:

• Audit Batch Numbers: Cross-reference the alphanumeric codes printed on the bottom of your formula cans against the official recall lists provided on the websites of the Food Standards Agency (FSA), UKHSA, or the manufacturer carelines.

• Do Not Feed Suspicious Batches: If a batch matches the recall list, cease using it immediately. Remember, boiling the water will not make contaminated powder safe.

• Dispose or Return: Safely destroy the product or return it to your point of purchase for a full refund.

• Monitor for Symptoms: Watch for sudden onset vomiting or distinct lethargy. If symptoms occur within hours of a feeding, contact your pediatrician or local emergency health service immediately.

Medical Disclaimer

This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.

References

Scientific Studies & Regulatory Reports

• European Food Safety Authority (EFSA). (February 1, 2026). EFSA provides rapid risk assessment on cereulide in infant formula. EFSA Journal, 2026;24(2):e09984.